BioLargo Q3 2025 Earnings Results Webcast and Conference Call on Friday, November 14th, 2025 - 4:30 PM Eastern Time

Rhea-AI Summary

BioLargo (OTCQX:BLGO) will host an investor webcast and conference call on Friday, November 14, 2025 at 1:30 PM PT / 4:30 PM ET to review results for the quarter ended September 30, 2025, discuss recent milestones, and hold a Q&A session.

Live access: register at the webcast page at least 15 minutes early. Teleconference numbers and participant code are provided for domestic and international callers. A replay is available through February 14, 2027, and the webcast replay plus presentation materials will be posted on BioLargo's Investor Relations page at www.biolargo.com/investor-relations.

WESTMINSTER, CA / ACCESS Newswire / November 13, 2025 / BioLargo, Inc. (OTCQX:BLGO), a developer of sustainable technologies and full-service environmental engineering company, announced it will host an investor webcast and conference call on Friday, November 14^th, 2025, at 1:30 pm Pacific / 4:30 pm Eastern. The event, which will be open to the public, will be held to review the company's financial results for the three months ending September 30^th, 2025, discuss recent milestones, and conduct a question-and-answer session.

To listen to a live broadcast, go to the site linked below at least 15 minutes prior to the scheduled start time to register and download any necessary audio/video software.

To participate in the live webcast and teleconference:

Webcast Link:	https://www.webcaster4.com/Webcast/Page/2448/53245
Teleconference Domestic:	877-545-0320
Teleconference International: Participant Access Code:	+1-973-528-0002 517720

To watch or listen to a replay of the webcast or teleconference:

Teleconference Replay Expiration:	Sunday, February 14th, 2027
Teleconference Replay Domestic:	877-481-4010
Teleconference Replay International:	919-882-2331
Replay Passcode:	53245

The webcast replay and accompanying presentation materials will be made available on the Investor Relations section of BioLargo's website at www.biolargo.com/investor-relations.

About BioLargo, Inc.
BioLargo, Inc. (OTCQX:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, enable energy-efficiency and safe on-site energy storage, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact. See our website at www.BioLargo.com.

Contact Information
Dennis P. Calvert
President and CEO, BioLargo, Inc.
888-400-2863

Safe Harbor Act
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include without limitation those about BioLargo's (the "Company") expectations regarding anticipated revenue; and plans for future operations. These statements involve risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements. Risks and uncertainties include without limitation: the effect of regional economic conditions on the Company's business, including effects on purchasing decisions by consumers and businesses; the ability of the Company to compete in markets that are highly competitive and subject to rapid technological change; the ability of the Company to manage frequent introductions and transitions of products and services, including delivering to the marketplace, and stimulating customer demand for, new products, services, and technological innovations on a timely basis; the dependency of the Company on the performance of distributors of the Company's products. More information on these risks and other potential factors that could affect the Company's business and financial results is included in the Company's filings with the SEC, including in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of the Company's most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings. The Company assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.

SOURCE: BioLargo, Inc

View the original press release on ACCESS Newswire

FAQ

When is BioLargo's BLGO Q3 2025 earnings webcast and conference call?

The webcast and call are on Friday, November 14, 2025 at 1:30 PM PT / 4:30 PM ET.

How can I join the BioLargo (BLGO) live webcast on November 14, 2025?

Go to the webcast page and register at least 15 minutes before start: https://www.webcaster4.com/Webcast/Page/2448/53245.

What are the BioLargo teleconference numbers and passcode for the November 14, 2025 call?

Domestic: 877-545-0320; International: +1-973-528-0002 with participant code 517720.

How long will the BLGO webcast replay be available and where can I find it?

The teleconference replay is available until February 14, 2027; the replay and presentation will be on BioLargo's Investor Relations page.

What will BioLargo cover during the Q3 2025 webcast and call?

The company will review financial results for the quarter ended September 30, 2025, discuss recent milestones, and hold a Q&A session.

Where can investors find BioLargo (BLGO) presentation materials after the webcast?

Presentation materials and the webcast replay will be posted at www.biolargo.com/investor-relations.